Effect of beta-blockers on QT dynamics in the long QT syndrome: Measuring the benefit

Europace

Volumn 16, Issue 12, 2014, Pages 1847-1851

  Bennett, Matthew T ^a   Gula, Lorne J ^b   Klein, George J ^b   Skanes, Allan C ^b   Yee, Raymond ^b   Leong Sit, Peter ^b   Chattha, Ishvinder ^b   Sy, Raymond ^c   Jones, Douglas L ^b   Krahn, Andrew D ^a  

^a Gordon and Leslie Diamond Health Care Centre Vancouver Coastal Health   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Beta blocker; Electrocardiography; Exercise testing; Long QT syndrome; QT interval

Indexed keywords

BISOPROLOL; POTASSIUM CHANNEL KCNQ1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; GENE MUTATION; HEART RATE; HUMAN; LONG QT SYNDROME 1; MALE; PRIORITY JOURNAL; QT INTERVAL; CLINICAL TRIAL; DRUG EFFECTS; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY; ROMANO-WARD SYNDROME; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; ROMANO-WARD SYNDROME; TREATMENT OUTCOME;

EID: 84928323217     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu086     Document Type: Article

References (36)

1. Priori SG, Barhanin J, Hauer RN, HaverkampW, Jongsma HJ, KleberAGet al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation 1999;99:674-81.
2. VincentGM.The molecular genetics of the longQTsyndrome: genes causing fainting and sudden death. Annu Rev Med 1998;49:263-74.
3. ShimizuW, McMahon B, Antzelevitch C. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome. J Cardiovasc Electrophysiol 1999;10:154-64.
4. Jons C, Moss AJ, Lopes CM, McNitt S, ZarebaW, Goldenberg I et al. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol 2009;20:859-65.
5. Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007;115:2481-9.
6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of theAmerican College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8: 746-837.
7. Moss AJ, ZarebaW, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000;101:616-23.
8. Shimizu W, Antzelevitch C. Differential effects of beta-Adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000;35:778-86.
9. Viitasalo M, Oikarinen L, Swan H, Vaananen H, Jarvenpaa J, HietanenHet al. Effects of beta-blocker therapy on ventricular repolarization documented by 24-h electrocardiography in patients with type 1 long-QT syndrome. J Am Coll Cardiol 2006;48: 747-53.
10. SyRW, Chattha IS, Klein GJ, Gula LJ, SkanesAC, Yee R et al. Repolarization dynamics during exercise discriminate between LQT1 and LQT2 genotypes. J Cardiovasc Electrophysiol 2010;21:1242-46.
11. Chattha IS, Sy RW, Yee R, Gula LJ, Skanes AC, Klein GJ et al. Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? Heart Rhythm 2010;7:906-11.
12. Walker BD, Krahn AD, Klein GJ, Skanes AC, Yee R. Burst bicycle exercise facilitates diagnosis of latent long QT syndrome. Am Heart J 2005;150:1059-63.
13. Chauhan VS, Krahn AD, Mitoff P, Klein GJ, Skanes AC, Yee R. Sudden intense exercise increasesQT heart rate slope and Twave complexity in longQT syndrome and normal subjects. Pacing Clin Electrophysiol 2004;27:1415-23.
14. McLaughlin NB, Campbell RW, Murray A. Comparison of automatic QT measurement techniques in the normal 12 lead electrocardiogram. Br Heart J 1995;74:84-9.
15. Savelieva I, Yi G, Guo X, Hnatkova K, Malik M. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol 1998;81:471-7.
16. Postema PG, De Jong JS, Van der Bilt IA, Wilde AA. Accurate electrocardiographic assessment of the QT interval: teach the tangent. Heart Rhythm 2008;5:1015-8.
17. Bazett H. An analysis of the time relations of electrocardiograms. Heart 1920;7:1920.
18. LS F. Die Systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand 1920;53:489.
19. Thiene G, Carturan E, CorradoD, Basso C. Prevention of sudden cardiac death in the young and in athletes: dream or reality? Cardiovasc Pathol 2009;19:207-17.
20. GrayC, Gula LJ, Klein GJ, SkanesAC, YeeR, SyRet al. Expression of acommonLQT1 mutation in five apparently unrelated families in a regional inherited arrhythmia clinic. J Cardiovasc Electrophysiol 2009;21:296-300.
21. Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol 2008;51:2291-300.
22. Kaufman ES,McNitt S, Moss AJ, ZarebaW, Robinson JL, HallWJet al. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm 2008;5:831-6.
23. Sakaguchi T, Shimizu W, Itoh H, Noda T, Miyamoto Y, Nagaoka I et al. Age-And genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol 2008;19:794-9.
24. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999;97:175-87.
25. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
26. Krahn AD, Yee R, Chauhan V, Skanes AC, Wang J, Hegele RA et al. Beta blockers normalize QT hysteresis in long QT syndrome. Am Heart J 2002;143: 528-34.
27. Gemma LW,Ward GM, Dettmer MM, Ball JL, Leo PJ, DoriaDN et al. Beta-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1. J Cardiovasc Electrophysiol 2011;22:1141-6.
28. Hobbs JB, Peterson DR, Moss AJ, McNitt S, ZarebaW, Goldenberg I et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006;296:1249-54.
29. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E et al. Association of long QT syndrome loci and cardiac events among patients treated with betablockers. JAMA 2004;292:1341-4.
30. ShimizuW, Tanabe Y, Aiba T, Inagaki M, Kurita T, Suyama K et al. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2002;39:1984-91.
31. Dorostkar PC, Eldar M, Belhassen B, Scheinman MM. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 1999;100:2431-6.
32. Goldenberg I, Moss AJ, Peterson DR, McNitt S, ZarebaW, Andrews ML et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008;117:2184-91.
33. Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S et al. Long-QT syndrome after age 40. Circulation 2008;117:2192-201.
34. Sauer AJ, Moss AJ, McNitt S, Peterson DR, ZarebaW, Robinson JL et al. Long QT syndrome in adults. J Am Coll Cardiol 2007;49:329-37.
35. ShimizuW, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M et al. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol 2004;44:117-25.
36. Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT et al. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009; 54:2052-62.